APA (7th ed.) Citation

IM, S., OI, E., SM, M., I, S., MA, A., FA, A., . . . TS, I. (2025). Exploitation of novel pyrazolo[3,4-d]pyrimidine scaffold tethered to thiazole as potential EGFR/HER2 dual kinase inhibitor to overcome lapatinib resistant breast cancer: Design, synthesis, in silico docking and molecular dynamic simulation. Bioorganic chemistry, 163, 108671. https://doi.org/10.1016/j.bioorg.2025.108671

Chicago Style (17th ed.) Citation

IM, Salem, et al. "Exploitation of Novel Pyrazolo[3,4-d]pyrimidine Scaffold Tethered to Thiazole as Potential EGFR/HER2 Dual Kinase Inhibitor to Overcome Lapatinib Resistant Breast Cancer: Design, Synthesis, in Silico Docking and Molecular Dynamic Simulation." Bioorganic Chemistry 163 (2025): 108671. https://doi.org/10.1016/j.bioorg.2025.108671.

MLA (9th ed.) Citation

IM, Salem, et al. "Exploitation of Novel Pyrazolo[3,4-d]pyrimidine Scaffold Tethered to Thiazole as Potential EGFR/HER2 Dual Kinase Inhibitor to Overcome Lapatinib Resistant Breast Cancer: Design, Synthesis, in Silico Docking and Molecular Dynamic Simulation." Bioorganic Chemistry, vol. 163, 2025, p. 108671, https://doi.org/10.1016/j.bioorg.2025.108671.